Search Results 1821-1830 of 19611 for Hemoglobin

1. Neurology - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

2. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

   Hemoglobin > 9 g/dL without transfusion or erythropoiesis stimulating agents dependency; Serum creatinine ≤ 1.5 x upper limit of normal (ULN); Total serum ...

3. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

   Hemoglobin ≤ 9.5 g/dL. Absolute neutrophil count < 1,000 per mm^3. History of known anti-GM-CSF autoAb or tests positive at screening, or history of ...

4. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Creatinine ≤ 2 x ULN;; SGOT (AST) ≤ 2 x ULN;; Albumin ≥ 3 g/dL. Willing and able to swallow capsules. Willing and able to complete ...

5. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

   * Hemoglobin \>= 8.0 g/dL (=\< 14 days prior to registration) * Absolute neutrophil count (ANC) \>= 500/mm\^3 (=\< 14 days prior to registration) * Platelet ...

6. A Study of RP2 with Nivolumab compared to Ipilimumab with Nivolumab with Metastatic Uveal Melanoma - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (without packed red blood cell [RBC] transfusion within 2 weeks of dosing). Has adequate hepatic function based on central laboratory ...

7. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Hemoglobin 9.0 g/dL;; Serum creatinine 1.5 x ULN or creatinine clearance (CrCl) 30 mL/min (using the Cockcroft-Gault formula):. Female CrCl = (140 - age in ...

8. Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT) - Mayo Clinic

   Diagnosed reduced lung function with either diffusion capacity (corrected for hemoglobin) or forced expiratory volume in 1 second (FEV1) ≤65% of predicted ...

9. Neurology - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

10. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    Hemoglobin > 9 g/dL;; Absolute neutrophil count ≥ 1,500/mcL;; Platelets ≥ 100,000/mcL;; Total bilirubin ≤ 2 × institutional upper limit of normal (ULN);; AST ...